Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mia G. J. Koolen"'
Autor:
Meike W. van Hoek, Mia G. J. Koolen, Apollonia L. J. Uitterhoeve, Jan Wiersma, Jouke T. Annema, Hein J. Verberne, Coen R.N. Rasch, Rob M. van Os, Edith M.T. Dieleman, Judit A. Adam, Caro C.E. Koning, M.W. Kolff
Publikováno v:
International Journal of Radiation Oncology-Biology-Physics, 102(3), 543-551. ELSEVIER SCIENCE INC
International journal of radiation oncology, biology, physics, 102(3), 543-551. Elsevier Inc.
International journal of radiation oncology, biology, physics, 102(3), 543-551. Elsevier Inc.
Purpose: The purpose of this study was to determine survival, local and distant control, toxicity, and prognostic factors in patients with stage III non-small cell lung cancer (NSCLC) treated with concurrent chemoradiation therapy (CCRT).Methods and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59131d8cab41130991c384dd4c3dbc93
https://hdl.handle.net/1887/3280369
https://hdl.handle.net/1887/3280369
Autor:
Mia G. J. Koolen, Jikke M.T. Omloo, Jacques J. Bergman, Mark I. van Berge Henegouwen, Mark van Heijl, J. Jan B. van Lanschot
Publikováno v:
Journal of gastrointestinal surgery, 12(11), 1874-1879. Springer New York
Introduction Esophageal cancer is an aggressive disease with a strong tendency to infiltrate into surrounding structures. The aim of the present study is to determine the additional value of bronchoscopy for detecting invasion of the tracheobronchial
Autor:
Harry Bartelink, P.J.M. van der Vaart, C.C.M. Koning, P. Rodrigus, D. González González, José Belderbos, Mia G. J. Koolen, Apollonia L.J. Uitterhoeve, J. Benraadt
Publikováno v:
European Journal of Cancer. 36:592-600
The purpose of this work was to study the feasibility of concurrent chemoradiation in patients with inoperable non-small cell lung cancer (NSCLC). 40 patients with inoperable NSCLC were treated with escalating doses of radiotherapy and cisplatin (cDD
Autor:
Mia G. J. Koolen, Robert Tepaske, Anton Vonk-Noordegraaf, Jan Frassdorf, René E. Jonkers, Elisabeth H. Bel, Jaap J. Kloek, Peter I. Bonta
Publikováno v:
D68. PULMONARY VASCULAR DISEASES: CLINICAL CASES.
Autor:
Mia G. J. Koolen, D. González González, Peter Sminia, A.L.J. Schuster-Uitterhoeve, Maarten C.C.M. Hulshof
Publikováno v:
Radiotherapy and Oncology, 28(3), 247-51. Elsevier Ireland Ltd
Schuster-Uitterhoeve, A L, Hulshof, M C, Gonzàlez Gonzàlez, D, Koolen, M & Sminia, P 1993, ' Feasibility of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer (NSCLC) ', Radiotherapy and Oncology, vol. 28, no. 3, pp. 247-51 .
Radiotherapy and oncology, 28(3), 247-251. Elsevier Ireland Ltd
Schuster-Uitterhoeve, A L, Hulshof, M C, Gonzàlez Gonzàlez, D, Koolen, M & Sminia, P 1993, ' Feasibility of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer (NSCLC) ', Radiotherapy and Oncology, vol. 28, no. 3, pp. 247-51 .
Radiotherapy and oncology, 28(3), 247-251. Elsevier Ireland Ltd
Thirty-three patients with an inoperable NSCLC were treated with a dose of 60 Gy/20 fractions/25 days, using a concomitant boost technique. A dose of 40 Gy/2 Gy/25 days was given to the tumor area and a part (15 patients) or the whole (18 patients) m
Autor:
Bradley R. Pieters, Apollonia L. J. Uitterhoeve, Caro C.E. Koning, Kees Koedooder, Rob M. van Os, Mia G. J. Koolen, Marlou van de Kar
Publikováno v:
Radiation Oncology (London, England)
Radiation oncology (London, England), 2. BioMed Central
Radiation Oncology, Vol 2, Iss 1, p 27 (2007)
Radiation oncology (London, England), 2. BioMed Central
Radiation Oncology, Vol 2, Iss 1, p 27 (2007)
Background Results of high-dose chemo-radiotherapy (CRT), using the treatment schedules of EORTC study 08972/22973 or radiotherapy (RT) alone were analyzed among all patients (pts) with Non Small Cell Lung Cancer (NSCLC) treated with curative intent
Autor:
J. Benraadt, D. González González, A.L.J. Schuster-Uitterhoeve, Harry Bartelink, P.J.M. van de Vaart, Mia G. J. Koolen, C. Schaake-Koning
Publikováno v:
European journal of cancer (Oxford, England, 32A(8), 1314-1319. Elsevier Limited
The aim of this study was to determine whether it is feasible to reduce the overall treatment time from 7 to 4 weeks in patients with non-small cell lung cancer (NSCLC) receiving radiotherapy with cisplatin. This follows an EORTC phase III randomised
Autor:
J. Jan B. van Lanschot, Jikke M.T. Omloo, Mark I. van Berge Henegouwen, Mark van Heijl, Mia G. J. Koolen, Jacques J. Bergman
Publikováno v:
Gastroenterology. 134:A-902
Publikováno v:
Lung Cancer. 8:355